Gateway Wealth Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Gateway Wealth Partners's FBT Position: Q2 2026 in Review
Gateway Wealth Partners reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 83% in Q2 2026, selling an estimated $3.53M and leaving 3,244 shares worth $804K. The position accounts for 0.05% of the portfolio, ranked #358.
Gateway Wealth Partners first reported a position in FBT in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.95M in Q1 2026. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Gateway Wealth Partners held 3,244 shares of First Trust NYSE Arca Biotechnology Index Fund worth $804K as of Q2 2026.
- Gateway Wealth Partners sold 16,410 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $3.53M.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.05% of Gateway Wealth Partners's portfolio in Q2 2026, its #358 holding.
- Gateway Wealth Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 10 quarters since.
- Gateway Wealth Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.95M in Q1 2026.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Gateway Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.